US hospital initiative improves on-time administration of Parkinson’s medication

News

Author: Simge Eva DoganPublished: 16 July 2020

Prep: Cook: Serves:

Late or missed doses of Parkinson’s medication in hospitals can lead to longer stays and greater morbidity. To counteract this issue, a team of healthcare professionals in the US launched a project to improve the on-time administration of medication to people with the condition.

As part of the initiative – published in the Journal of Parkinson’s Disease – several measures were implemented, including electronic alerts for nurses, stocking automated medication dispensing machines, reporting to nurse unit managers on timeliness of medication administration and more.

Dr Martha A Nance, the project’s lead investigator, said: “This project was very rewarding for our team, because of its obvious, immediate, and important impact on patient care.

“We have reason to think that timely administration of carbidopa-levodopa may be associated with shorter stays and better outcomes and satisfaction. Anecdotally, patients have reported being surprised and pleased that nurses were reminding them that medication doses were due soon, rather than the other way around!”

To read more on this topic click here.

For more information on Parkinson’s and hospital admission please visit the EPDA website.

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Dancing with Parkinson’s: “I feel completely changed”

We talk to Parkinson’s campaigner Massimiliano Iachini

Covid-19 and Parkinson’s disease: a lasting impact?

Exploring the link between pandemics, viruses and the condition

“We want the feeling of togetherness to take centre stage”

An exciting table tennis event for the Parkinson’s disease community

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

Could a specialised smartwatch support people with Parkinson’s disease?

A specialised smartwatch, which could help those living with Parkinson’s to better manage their condition, will be rolled out to thousands of people in England. The Parkinson’s Kinetigraph, developed by the National Health Service (NHS) in Plymouth and the University of Plymouth, UK, contains sensors designed to monitor the wearer’s activity and buzz with medication reminders. Data collected from the watch – which detects excessive movement, immobility and sleep disturbances – is shared with healthcare providers, allowing for improvements to physiotherapy and prescriptions based on patient needs. Commenting on the smartwatch’s launch, NHS England chief executive Amanda Pritchard said: “Not only is it better for these people living with Parkinson’s, but it is also more efficient for the NHS, freeing up space and time in hospitals for our hard-working staff.” UK health secretary Sajid Javid, meanwhile, described the Kinetigraph as a “fantastic example of how technology is driving cutting-edge innovation…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

US hospital initiative improves on-time administration of Parkinson’s medication

News

Author: Simge Eva DoganPublished: 16 July 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Dancing with Parkinson’s: “I feel completely changed”

Global update

Covid-19 and Parkinson’s disease: a lasting impact?

Global update

“We want the feeling of togetherness to take centre stage”

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

Could a specialised smartwatch support people with Parkinson’s disease?

{title}

Subscribe

US hospital initiative improves on-time administration of Parkinson’s medication

News

Author: Simge Eva DoganPublished: 16 July 2020

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Dancing with Parkinson’s: “I feel completely changed”

Global update

Covid-19 and Parkinson’s disease: a lasting impact?

Global update

“We want the feeling of togetherness to take centre stage”

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

Could a specialised smartwatch support people with Parkinson’s disease?

{title}

Subscribe

Sign in